Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if complex lymphedema therapy is effective in decreasing disease severity and improving quality of life in patients with post thrombotic syndrome.


Clinical Trial Description

Post thrombotic syndrome (PTS) has a spectrum of disease manifestations ranging from minor skin discoloration to severe skin changes and venous ulcerations. Pain is often a prominent symptoms and PTS impairs patient quality of life. Prevention of PTS using compression stockings has been emphasized. There is a paucity of validated, effective treatments for PTS once the condition develops.

While the pathophysiology of PTS is incompletely understood, chronic venous hypertension and insufficiency may increase the workload of the lymphatic system and result in over-capacitance with secondary damage and eventual lymphatic insufficiency. In selected patients with PTS, we have noted a symptomatic improvement in patients who receive lymphedema therapy to the limb.

Complex lymphedema therapy (CLT) is a noninvasive treatment that includes four key components: meticulous skin care, manual lymph drainage, compression therapy, exercises and patient education for home management and continuation of the treatment. These techniques are designed to enhance lymph flow through intact cutaneous lymphatics and reduce swelling and restore function in the affected limb. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00633971
Study type Interventional
Source University of Vermont
Contact
Status Completed
Phase N/A
Start date March 2008
Completion date September 2011

See also
  Status Clinical Trial Phase
Recruiting NCT05744843 - Structured Exercise Versus Endovascular Reconstruction in Post Thrombotic Syndrome N/A
Recruiting NCT05622500 - Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease N/A
Recruiting NCT05296499 - EXERT: Exercise Physiology After Thrombosis
Recruiting NCT04250025 - Angioplasty-stenting vs Optimal Medical Treatment on Post-thrombotic Syndrome Reduction N/A
Completed NCT00790335 - Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis Phase 3
Completed NCT03075761 - Physical Activity in Children at Risk of Post-thrombotic Sequelae (PACT) N/A
Terminated NCT04794569 - Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome Phase 4
Recruiting NCT03368313 - Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis N/A
Terminated NCT04103112 - Compression Hosiery to Avoid Post-Thrombotic Syndrome N/A
Completed NCT00858130 - Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome (PTS) N/A
Recruiting NCT06046807 - Long-Term Post Thrombotic Syndrome Assessment (CELEST Long Term).
Not yet recruiting NCT01637428 - The Use of Intermittent Pneumatic Compression Device for Symptomatic Relief in Patients With Post Thrombotic Syndrome Phase 2
Recruiting NCT03250247 - Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial) N/A
Completed NCT03054727 - Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )
Completed NCT04825548 - Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 Protocol
Withdrawn NCT03039517 - Post Thrombotic Syndrome Prevention Study N/A
Recruiting NCT02268630 - Long Term Outcomes of Venous Thromboembolism N/A
Completed NCT03757481 - Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE N/A
Recruiting NCT04319627 - Statins for Venous Event Reduction in Patients With Venous Thromboembolism Phase 3
Withdrawn NCT04411316 - Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis Phase 4